Evoke Wealth LLC Has $5.38 Million Stake in Colgate-Palmolive (NYSE:CL)

Evoke Wealth LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 1.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,189 shares of the company’s stock after selling 741 shares during the quarter. Evoke Wealth LLC’s holdings in Colgate-Palmolive were worth $5,381,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of CL. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $33,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of several research analyst reports. Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Price Performance

Shares of CL opened at $90.72 on Tuesday. The firm has a market capitalization of $73.62 billion, a PE ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company’s 50-day moving average is $89.09 and its 200-day moving average is $94.56. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.